Research Article
Complementary and Alternative Medicine Use among Norwegian Cancer Survivors: Gender-Specific Prevalence and Associations for Use
Table 4
Overall CAM use. Health-related characteristics of users and nonusers.
| | | CAM users | Nonusers of CAM | | CAM users | Nonusers of CAM | | Interaction | | | Women |
Women | -value | Men |
Men | -value | women/men | | | (*) |
(*) | (*) |
(*) | | | | () | % | () | % | | () | % | () | % | | -value |
| | Self-reported health | | | | | | | | | | | | | Medium to good health | (114) | 90.5 | (181) | 92.3 | 0.554 | (74) | 88.1 | (199) | 91.3 | 0.399 | 0.852 | | Poor health | (12) | 9.5 | (15) | 7.7 | | (10) | 11.9 | (19) | 8.7 | | | | Time since diagnosis | | | | | | | | | | | | | Less than one year | (5) | 3.9 | (5) | 2.5 | 0.819 | (3) | 3.5 | (17) | 7.7 | 0.479 | 0.737 | | 1–5 years | (33) | 25.8 | (46) | 23.4 | | (34) | 40 | (74) | 33.6 | | | | 5–10 years | (35) | 27.3 | (60) | 30.5 | | (22) | 25.9 | (56) | 25.5 | | | | More than 10 years | (55) | 43 | (86) | 43.7 | | (26) | 30.6 | (73) | 33.2 | | | | Cancer localization | | | | | | | | | | | | | Breast | (57) | 44.5 | (66) | 33.5 | 0.193 | | | | | | | | Cervix uteri | (4) | 3.1 | (13) | 6.6 | | | | | | | | | Other parts of uterus | (4) | 3.1 | (14) | 7.1 | | | | | | | | | Ovary | (10) | 7.8 | (7) | 3.6 | | | | | | | | | Prostate | | | | | | (35) | 41.2 | (71) | 32.3 | 0.439 | | | Testis | | | | | | (3) | 3.5 | (17) | 7.7 | | | | Colon | (9) | 7.0 | (14) | 7.1 | | (4) | 4.7 | (18) | 8.2 | | | | Bladder | (2) | 1.6 | (8) | 4.1 | | (7) | 8.2 | (15) | 6.8 | | | | Rectum and anus | (4) | 3.1 | (4) | 2.0 | | (5) | 5.9 | (10) | 4.5 | | | | Trachea, bronchus, and lung | (1) | 0.8 | (4) | 2.0 | | (4) | 4.7 | (6) | 2.7 | | | | Lymphoid | (7) | 5.5 | (9) | 4.6 | | (4) | 4.7 | (17) | 7.7 | | | | Kidney | (0) | 0 | (1) | 0.5 | | (1) | 1.2 | (10) | 4.5 | | | | All other cancer sites | (30) | 23.4 | (57) | 28.9 | | (22) | 25.9 | (56) | 25.5 | | | | Breast cancer | | | | | | | | | | | | | Breast | (57) | 44.5 | (66) | 33.5 | 0.045 | | | | | | | | Other sites | (71) | 55.5 | (131) | 66.5 | | (85) | 100 | (220) | 100 | | | | Prostate cancer | | | | | | | | | | | | | Prostate | | | | | | (35) | 41.2 | (71) | 32.3 | 0.143 | | | Other sites | (128) | 100 | (197) | 100 | | (50) | 58.8 | (149) | 67.7 | | | | Metastases | | | | | | | | | | | | | Metastases at first diagnosis | (27) | 21.1 | (54) | 27.4 | 0.415 | (12) | 14.1 | (37) | 16.8 | 0.487 | 0.953 | | No metastases | (73) | 57 | (106) | 53.8 | | (49) | 57.6 | (110) | 50 | | | | Unknown | (28) | 21.9 | (37) | 18.8 | | (24) | 28.2 | (73) | 33.2 | | |
|
|
*Due to missing response on one or more variables, the analysed numbers do not always add up to the total number.
|
